首页> 外文期刊>NeuroImage >A systematic review of the reporting of sample size calculations and corresponding data components in observational functional magnetic resonance imaging studies
【24h】

A systematic review of the reporting of sample size calculations and corresponding data components in observational functional magnetic resonance imaging studies

机译:对观察性功能磁共振成像研究中样本量计算和相应数据组成的报告的系统综述

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Anecdotal evidence suggests that functional magnetic resonance imaging (fMRI) studies rarely consider statistical power when setting a sample size. This raises concerns since undersized studies may fail to detect effects of interest and encourage data dredging. Although sample size methodology in this field exists, implementation requires specifications of estimated effect size and variance components. We therefore systematically evaluated how often estimates of effect size and variance components were reported in observational fMRI studies involving clinical human participants published in six leading journals between January 2010 and December 2011. A random sample of 100 eligible articles was included in data extraction and analyses. Two independent reviewers assessed the reporting of sample size calculations and the data components required to perform the calculations in the fMRI literature. One article (1%) reported sample size calculations. The reporting of parameter estimates for effect size (8%), between-subject variance (4%), within-subject variance (1%) and temporal autocorrelation matrix (0%) was uncommon. Three articles (3%) reported Cohen's d or F effect sizes. The majority (83%) reported peak or average t, z or F statistics. The inter-rater agreement was very good, with a prevalence-adjusted bias-adjusted kappa (PABAK) value greater than 0.88. We concluded that sample size calculations were seldom reported in fMRI studies. Moreover, omission of parameter estimates for effect size, between- and within-subject variances, and temporal autocorrelation matrix could limit investigators' ability to perform power analyses for new studies. We suggest routine reporting of these quantities, and recommend strategies for reducing bias in their reported values.
机译:轶事证据表明,功能磁共振成像(fMRI)研究在设置样本量时很少考虑统计功效。这引起了人们的关注,因为规模较小的研究可能无法检测到感兴趣的影响并鼓励数据挖掘。尽管存在该领域的样本量方法论,但实施需要规范估计的效应量和方差成分。因此,我们系统地评估了在2010年1月至2011年12月之间发表在六本主要期刊上的涉及临床人类参与者的观察性fMRI研究中,多久报告一次效应大小和方差成分的估计。数据抽取和分析包括100篇合格文章的随机样本。两名独立的审阅者评估了fMRI文献中样本量计算的报告以及执行计算所需的数据成分。一篇文章(占1%)报告了样本量计算。关于效果大小(8%),受试者间差异(4%),受试者内差异(1%)和时间自相关矩阵(0%)的参数估计的报告并不常见。三篇文章(占3%)报道了Cohen的d或F效应大小。大多数(83%)报告了t,z或F的峰值或平均值统计。评估者之间的协议非常好,患病率调整后的偏差调整过的Kappa(PABAK)值大于0.88。我们得出的结论是,在功能磁共振成像研究中很少报告样本量计算。此外,省略针对效应大小,受试者之间和受试者内部方差以及时间自相关矩阵的参数估计,可能会限制研究人员进行新研究的功效分析的能力。我们建议常规报告这些数量,并建议减少其报告值偏差的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号